Identification of ACKR4 as an immune checkpoint in pulmonary arterial hypertension
ObjectiveInflammation is recognized as a contributor in the development of pulmonary arterial hypertension (PAH), and the recruitment and functional capacity of immune cells are well-orchestrated by chemokines and their receptors. This study is aimed at identification of critical chemokines in the p...
Main Authors: | Chen-Yu Jiang, Li-Wei Wu, Yi-Wei Liu, Bei Feng, Lin-Cai Ye, Xu Huang, Yang-Yang He, Yi Shen, Yi-Fan Zhu, Xing-Liang Zhou, Dai-Ji Jiang, Hai-Kun Qi, Hao Zhang, Yi Yan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-06-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1153573/full |
Similar Items
-
Corrigendum: Identification of ACKR4 as an immune checkpoint in pulmonary arterial hypertension
by: Chen-Yu Jiang, et al.
Published: (2024-02-01) -
The Role of the CXCL12/CXCR4/ACKR3 Axis in Autoimmune Diseases
by: Eva M. García-Cuesta, et al.
Published: (2019-08-01) -
Emerging Roles of the Atypical Chemokine Receptor 3 (ACKR3) in Cardiovascular Diseases
by: Vincent Duval, et al.
Published: (2022-06-01) -
D6/ACKR2
by: Gerry eGraham
Published: (2015-06-01) -
Prospects for targeting ACKR1 in cancer and other diseases
by: Kyler S. Crawford, et al.
Published: (2023-03-01)